Thursday, Mar 28, 2024
engineered enzymes for better healthcare

An Irish company was due to launch a novel newborn screening test for phenylketonuria (PKU) at a major international meeting in Prague this week. Enzolve Technologies was due to formally launch its diagnostic test at the 6th International Society for Neonatal Screening European Regional Meeting, which took place in Prague from April 26-28...

Read full article on the web     Irish Medical Times Apr 29, 2009     or in pdf format   pdf_button

 

  Back to the News page 

Language Selection

Search